Skip to content
Screener

MiMedx Group MDXG Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$22.93M+163%
Solventum logo
SolventumSOLV
$904M-1.4%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$10.66M+13.4%
IAR
Integra LifeSciencesIART
CorMedix logo
CorMedixCRMD
InfuSystem Holdings logo
InfuSystem HoldingsINFU

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemJune 30,2026December 31,2025
Deferred tax asset, net27,29519,596
Goodwill19,44119,441
Intangible assets, net12,08614,158
Other assets11,8977,274
Total assets$280,998$342,653
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long term debt$1,500$1,500

Item 1. Financial Statements

FAQ

What is MiMedx Group's deferred tax assets and other non-current assets?
MiMedx Group (MDXG) reported deferred tax assets and other non-current assets of $11.9M in Q2 2026.
How has MiMedx Group's deferred tax assets and other non-current assets changed year-over-year?
MiMedx Group's deferred tax assets and other non-current assets increased by 1101.7% year-over-year, from $990K to $11.9M.
What is the long-term trend for MiMedx Group's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), MiMedx Group's deferred tax assets and other non-current assets has grown at a 80.9% compound annual growth rate (CAGR), from $375K to $7.27M.

Ask your AI about MiMedx Group's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude